MYRIAD GENETICS, INC. (MYGN) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $120.70M; Long-term DebtUSD $120.70M; Long-term Debt, GrossUSD $125.00M.
- 2026-03-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $120.30M; Long-term DebtUSD $120.30M; Long-term Debt, GrossUSD $125.00M.
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $119.90M; Long-term DebtUSD $119.90M; Long-term Debt, GrossUSD $125.00M.
- 2025-09-30: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $119.50M; Long-term DebtUSD $119.50M; Long-term Debt, GrossUSD $125.00M.
MYRIAD GENETICS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-term Debt, Gross USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD | Short-term Debt USD | Debt, Current USD | Debt Instrument, Face Amount USD | Debt Instrument, Interest Rate, Effective Percentage pure | Debt Instrument, Unamortized Discount, Current USD | Debt Instrument, Unamortized Discount, Noncurrent USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $120.70M | $120.70M | $125.00M | $8.10M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $120.30M | $120.30M | $125.00M | $8.50M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $119.90M | $119.90M | $125.00M | $8.90M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $119.50M | $119.50M | $125.00M | $9.30M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-07-31 | (m) | (m) | (m) | $125.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $59.40M | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $59.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $39.60M | (m) | $40.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $39.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $38.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $38.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $38.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $38.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $38.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $0.00 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $104.10M | $0.00 | $104.10M | (m) | (m) | (m) | (m) | (m) | (m) | $2.30M | $0.00 |
| 2021-03-31 | (m) | (m) | $154.00M | $156.60M | (m) | (m) | (m) | (m) | (m) | (m) | $2.60M |
| 2020-12-31 | (m) | $224.80M | $224.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.90M |
| 2020-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) |
| 2020-12-31 | (m) | (m) | (m) | $226.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | $224.60M | $226.70M | (m) | (m) | (m) | (m) | (m) | (m) | $2.10M |
| 2020-06-30 | (m) | (m) | $224.40M | $226.70M | (m) | (m) | (m) | (m) | (m) | (m) | $2.30M |
| 2020-06-30 | (m) | $224.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $225.20M | $225.20M | $226.60M | (m) | (m) | (m) | (m) | (m) | (m) | $1.40M |
| 2019-12-31 | (m) | $225.10M | $225.10M | $226.60M | (m) | (m) | (m) | (m) | (m) | (m) | $1.50M |
| 2019-09-30 | (m) | $225.00M | $225.00M | $226.60M | (m) | (m) | (m) | (m) | (m) | (m) | $1.60M |
| 2019-06-30 | (m) | (m) | $233.50M | $235.00M | (m) | (m) | (m) | (m) | (m) | (m) | $1.50M |
| 2019-06-30 | (m) | $233.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $263.40M | $263.40M | $265.20M | (m) | (m) | (m) | (m) | (m) | (m) | $1.80M |
| 2018-12-31 | (m) | $273.30M | $273.30M | $275.30M | (m) | (m) | (m) | (m) | (m) | (m) | $2.00M |
| 2018-09-30 | (m) | $258.00M | $258.00M | $260.10M | (m) | (m) | (m) | (m) | (m) | (m) | $2.10M |
| 2018-06-30 | (m) | $9.30M | $9.30M | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | $700.00K |
| 2018-03-31 | (m) | $69.30M | $69.30M | $70.10M | (m) | (m) | (m) | (m) | (m) | (m) | $800.00K |
| 2017-12-31 | (m) | $43.20M | $43.20M | $44.00M | (m) | (m) | (m) | (m) | (m) | (m) | $800.00K |
| 2017-09-30 | (m) | (m) | $74.20M | $75.10M | $900.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $99.10M | $99.10M | $100.00M | (m) | (m) | (m) | (m) | (m) | (m) | $900.00K |
| 2017-06-30 | (m) | (m) | (m) | (m) | $900.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | $167.10M | $168.10M | $1.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | $204.00M | $205.00M | $1.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | $200.00M | $199.20M | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6.00% | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 7.00% | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6.00% | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6.00% | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6.00% | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6.00% | (m) | (m) |
| 2011-09-08 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $25.00M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |